SEC Form 4 · accession 0001209191-16-133358
IMMUNE DESIGN CORP. · IMDZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen R Brady
Officer — EVP, Strategy & Finance
Period of report
Jul 15, 2016
Accepted (ET)
Jul 19, 2016 · 5:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001437786
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 15, 2016 | P | 1,500 | $6.8369 | A | 17,132 | D |
Table II — derivative securities
No Table II lines on this filing.